These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8667206)

  • 1. NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release.
    Inoue H; Arai I; Shibata S; Watanabe S
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1424-30. PubMed ID: 8667206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of Nomega-nitro-L-arginine methyl ester on bromocriptine-induced locomotor sensitization in mice.
    Kayir H; Ceyhan M; Yavuz O; Uzbay IT
    Synapse; 2007 Oct; 61(10):869-74. PubMed ID: 17623833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
    Shuto T; Kuroiwa M; Hamamura M; Yabuuchi K; Shimazoe T; Watanabe S; Nishi A; Yamamoto T
    Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nitric oxide synthase inhibitor and NMDA receptor antagonist on the development of nicotine sensitization of nucleus accumbens dopamine release: an in vivo microdialysis study.
    Hong SK; Jung IS; Bang SA; Kim SE
    Neurosci Lett; 2006 Dec; 409(3):220-3. PubMed ID: 17046158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine.
    Bickerdike MJ; Abercrombie ED
    J Pharmacol Exp Ther; 1997 Aug; 282(2):818-26. PubMed ID: 9262346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
    Abekawa T
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):113-26. PubMed ID: 9086367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of dopamine release from the striatum through metabotropic glutamate receptor activation in methamphetamine sensitized rats.
    Arai I; Shimazoe T; Shibata S; Inoue H; Yoshimatsu A; Watanabe S
    Brain Res; 1996 Aug; 729(2):277-80. PubMed ID: 8877000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agmatine inhibits morphine-induced locomotion sensitization and morphine-induced changes in striatal dopamine and metabolites in rats.
    Wei XL; Su RB; Wu N; Lu XQ; Zheng JQ; Li J
    Eur Neuropsychopharmacol; 2007 Dec; 17(12):790-9. PubMed ID: 17604969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in behavior and central monoaminergic systems in the rat after repeated methamphetamine pretreatment: presynaptic regulatory mechanism].
    Ichikawa J
    Yakubutsu Seishin Kodo; 1988 Sep; 8(3):389-403. PubMed ID: 3250152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide mediates glutamate-evoked dopamine release in the medial preoptic area.
    Dominguez JM; Muschamp JW; Schmich JM; Hull EM
    Neuroscience; 2004; 125(1):203-10. PubMed ID: 15051159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.
    Fukami G; Hashimoto K; Koike K; Okamura N; Shimizu E; Iyo M
    Brain Res; 2004 Jul; 1016(1):90-5. PubMed ID: 15234256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats.
    Tsukamoto T; Iyo M; Tani K; Sekine Y; Hashimoto K; Ohashi Y; Suzuki K; Iwata Y; Mori N
    Psychopharmacology (Berl); 2001 Nov; 158(2):107-13. PubMed ID: 11702083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of nitric oxide synthase attenuates osmotic thirst in the rat.
    Kannan H; Iki K; Kunitake T; Shimokawa A; Saita M; Ishizuka Y; Hanamori T
    Neurobiology (Bp); 1995; 3(3-4):363-70. PubMed ID: 8696304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine.
    Taraska T; Finnegan KT
    J Pharmacol Exp Ther; 1997 Feb; 280(2):941-7. PubMed ID: 9023310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
    Kim CK; Rivier C
    J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral, neuroendocrine and thermoregulatory actions of apelin-13.
    Jászberényi M; Bujdosó E; Telegdy G
    Neuroscience; 2004; 129(3):811-6. PubMed ID: 15541902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide synthase inhibitors block behavioral sensitization to methamphetamine in mice.
    Ohno M; Watanabe S
    Eur J Pharmacol; 1995 Feb; 275(1):39-44. PubMed ID: 7539765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
    Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
    Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors.
    Kiss JP; Zsilla G; Vizi ES
    Neurochem Int; 2004 Sep; 45(4):485-9. PubMed ID: 15186914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of N omega-nitro-L-arginine methyl ester, a nitric oxide synthesis inhibitor, on stress- and morphine-induced prolactin release in male rats.
    Matton A; Bollengier F; Finné E; Vanhaelst L
    Br J Pharmacol; 1997 Jan; 120(2):268-72. PubMed ID: 9117119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.